Sen Xu

机构：Yantaishan Hospital · ORCID：0000-0001-5098-371X

发表论文 113 篇 · 总被引 3200 次 · h-index 31

代表论文

• Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy (2023 · International Immunopharmacology · 被引 37)
• Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma (2023 · BMC Cancer · 被引 22)
• Brain‐Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co‐Editing Leading to Potent Inhibition of Orthotopic Glioblastoma (2024 · Advanced Science · 被引 11)
• Danshensu methyl ester attenuated LPS-induced acute lung injury by inhibiting TLR4/NF-κB pathway (2024 · Respiratory Physiology & Neurobiology · 被引 7)
• PARP inhibitors accumulate B7-H3 on fibroblasts via blocking autophagic flux to potentiate immune evasion in ovarian cancer (2025 · OncoImmunology · 被引 5)
• Effect of pharmaceutical promotion and incentives offered by pharmaceutical companies on the prescribing pattern of medical students: a cross-sectional study from a developing nation Pakistan (2024 · Frontiers in Medicine · 被引 4)